Original filing (PDF)20251013140212NAL0003113138001

FIRST WAVE BIOPHARMA, INC.

Name: FIRST WAVE BIOPHARMA, INC. — ENTERO THERAPEUTICS, INC. 401(K) PLAN, Form 5500 (2024)
Creator: FIRST WAVE BIOPHARMA, INC.

Form 5500-SF

FILING_RECEIVED

ENTERO THERAPEUTICS, INC. 401(K) PLAN

401(k) retirement plan

Active participants

Accounts w/ balance

Plan assets (EOY)

$1.4M

Net assets (EOY)

$1.4M

Plan health score (directional)

/ 100

Grade A

Top-tier plan health

Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.

Compliance & disclosures

100

Concentration risk

Total plan cost

Vendor stack

100

Participation health

Decision-maker contacts

CFO / Head of HR / Benefits Manager — verified email + LinkedIn for FIRST WAVE BIOPHARMA, INC..

Plan sponsor

Name

FIRST WAVE BIOPHARMA, INC.

EIN

46-4993860

Address

777 YAMATO ROAD, SUITE 502 · BOCA RATON, FL · 33431

Phone

(561) 589-7020

Industry

Professional & Technical Servicessee all

Plan administrator

Same as plan sponsor.

Plan characteristics

Plan number

001

Plan year

2024

Plan year begin

2024-01-01

Tax period

2024-12-31

Filed

2025-10-13

Pension benefit codes

2E · Profit-sharing

2F · ERISA section 404(c)

2G · Total participant-directed accounts

2H · Partial participant-directed accounts

2J · 401(k) feature

2K · 401(m) arrangement

2T · Default investment account (QDIA)

3D · Pre-approved plan (master / prototype / VS)

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans

Similar-size Professional & Technical Services plans

COSMOBIOLABS, INC.

BELLATRIX PHARMACEUTICALS, INC. 401(K) PLAN

$1.4M · 3 participants

GATE BIOSCIENCE

GATE BIOSCIENCE 401(K) PLAN

$1.4M · 33 participants

CAMBRIAN WORKS, INC.

CAMBRIAN WORKS, INC. 401(K) PROFIT SHARING PLAN

$1.4M · 16 participants

SIGHTLINE INSTITUTE

SIGHTLINE INSTITUTE 401(K) PLAN

$1.4M · 18 participants

BON OPUS BIOSCIENCES LLC

BON OPUS BIOSCIENCES LLC DEFINED BENEFIT PLAN

$1.4M · 2 participants